SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carlos S. Kase, Ashkan Shoamanesh, Steven M. Greenberg, Louis R. Caplan, Stroke, 2016,

    CrossRef

  2. 2
    Victoria Jacobs, Michael J. Cutler, John D. Day, T. Jared Bunch, Atrial fibrillation and dementia, Trends in Cardiovascular Medicine, 2015, 25, 1, 44

    CrossRef

  3. 3
    Moustapha Atoui, Sampath Gunda, Dhanunjaya Lakkireddy, Left Atrial Appendage Closure Is Preferred to Chronic Warfarin Therapy, Cardiac Electrophysiology Clinics, 2015, 7, 3, 403

    CrossRef

  4. 4
    Tae-Jin Song, Yoonkyung Chang, Min-Jeong Shin, Ji Hoe Heo, Yong-Jae Kim, Low levels of plasma omega 3-polyunsaturated fatty acids are associated with cerebral small vessel diseases in acute ischemic stroke patients, Nutrition Research, 2015, 35, 5, 368

    CrossRef

  5. 5
    Tatjana S. Potpara, Gregory Y.H. Lip, Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk, Progress in Cardiovascular Diseases, 2015, 58, 2, 177

    CrossRef

  6. 6
    VICTORIA JACOBS, SCOTT C. WOLLER, SCOTT M. STEVENS, HEIDI T. MAY, TAMI L. BAIR, BRIAN G. CRANDALL, MICHAEL CUTLER, JOHN D. DAY, J. PETER WEISS, JEFFREY S. OSBORN, CHARLES MALLENDER, JEFFREY L. ANDERSON, T. JARED BUNCH, Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia, Journal of Cardiovascular Electrophysiology, 2015, 26, 11
  7. 7
    S. Horstmann, M. Möhlenbruch, C. Wegele, T. Rizos, M. Laible, G. Rauch, R. Veltkamp, Prevalence of atrial fibrillation and association of previous antithrombotic treatment in patients with cerebral microbleeds, European Journal of Neurology, 2015, 22, 10
  8. 8
    Shunya Takizawa, Fumiaki Tanaka, Kazutoshi Nishiyama, Yasuhiro Hasegawa, Eiichiro Nagata, Atsushi Mizuma, Sachiko Yutani, Taira Nakayama, Hiroyuki Kobayashi, Noriharu Yanagimachi, Takashi Okazaki, Kazuo Kitagawa, Protocol for Cerebral Microbleeds during the Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial, Journal of Stroke and Cerebrovascular Diseases, 2015, 24, 9, 2143

    CrossRef

  9. 9
    T.-J. Song, J. Kim, H. S. Lee, C. M. Nam, H. S. Nam, E. H. Kim, K. J. Lee, D. Song, J. H. Heo, Y. D. Kim, Differential impact of unrecognised brain infarction on stroke outcome in non-valvular atrial fibrillation, Thrombosis and Haemostasis, 2014, 112, 6, 1312

    CrossRef

  10. 10
    Tae-Jin Song, Jinkwon Kim, Hye Sun Lee, Chung Mo Nam, Hyo Suk Nam, Young Dae Kim, Ji Hoe Heo, Distribution of Cerebral Microbleeds Determines Their Association with Impaired Kidney Function, Journal of Clinical Neurology, 2014, 10, 3, 222

    CrossRef

  11. 11
    T. Lewalter, P. Kanagaratnam, B. Schmidt, M. Rosenqvist, J. E. Nielsen-Kudsk, R. Ibrahim, B. A. Albers, A. J. Camm, Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion, Europace, 2014, 16, 5, 626

    CrossRef

  12. 12
    A. H. V. Schapira, Recent advances in neurology 2013–2014, European Journal of Neurology, 2014, 21, 12